Published Date: 17 Mar 2023
Kottayam: Government General Hospital (GMC) Government of Kerala delay in paying Kottayam affects patient care and...
Read Full NewsQurAlis reported interim ANQUR trial results showing target engagement, a biomarker signal, and a trend toward slower functional decline with QRL-201 in ALS.
Servier reported that sevasemten did not meet its primary or secondary endpoints in the pivotal GRAND CANYON trial for Becker muscular dystrophy.
GLP-1 RAs Linked to Lower Diabetes, CV Risk than Metformin in Prediabetes
1.
Traveling to Die: The Latest Form of Medical Tourism
2.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
3.
Millions of men could benefit from faster scan to diagnose prostate cancer
4.
Datopotamab Deruxtecan Earns New Breast Cancer Indication
5.
Gotistobart Response Rate Bests Chemo in Pretreated NSCLC
1.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
2.
Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications
3.
Risk Assessment of Reduced Hematopoietic Reserve During Chronic Systemic Stress
4.
Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
5.
How Nutrition Can Support Patients During Cancer Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation